Trial Profile
Impact of Pemafibrate on coronary plaque characteristics in ACS patients
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Apr 2019
Price :
$35
*
At a glance
- Drugs Pemafibrate (Primary)
- Indications Hypertriglyceridaemia
- Focus Therapeutic Use
- 08 Apr 2019 Status changed from not yet recruiting to discontinued.
- 16 Oct 2018 New trial record